Do not settle, he says
Peptide Guide #1: Peptide Protocols & Handbook: Peptide Book for Weight Loss, Muscle Growth & Longevity Using BPC-157, GHK-cu & Tirzepatide Peptides [Galt, John] on Amazon.com
Only the concentration values change
These interactions are theoretical in the context of retatrutide and have not been formally characterised
Immediate medical attention is required if taste changes are accompanied by: Severe, persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, decreased urination) Severe abdominal pain, particularly if persistent or worsening Symptoms of pancreatitis (severe upper abdominal pain radiating to the back, nausea, vomiting) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Symptoms of hypoglycemia (if also taking insulin or sulfonylureas): shakiness, sweating, confusion, irritability These symptoms may indicate serious adverse effects requiring urgent evaluation, including pancreatitis, gallbladder disease, gastroparesis, or severe dehydration
The committees recommendation is not a binding decision, and the addition of BP-157, KPV, and any other peptides to the list will still have to go through a lengthy public rulemaking process